a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1927 clinical trials
Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers

The purpose of this study is to assess the efficacy of Manremyc food supplement for reduce the incidence of SARS-CoV-2 infection in a high risk population, as healthcare workers.

SARS
serologic test
acute respiratory syndrome (sars)
  • 0 views
  • 19 Feb, 2024
  • 5 locations
Diffusion MRI for Head and Neck Cancer

The proposed study is to investigate the feasibility of using quantitative diffusion MRI (dMRI) methods for accurate and comprehensive assessment of treatment response. dMRI is a powerful tool to probe treatment-induced change in tumors. It is a unique in vivo imaging technique sensitive to cellular microstructures at the scale of …

probe
head and neck cancer
chemoradiation therapy
squamous cell carcinoma of head and neck
cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Validation of Standardized Test Protocols to Assess the Impact of Visual Pathologies in Daily Life Activities

the incidence of the disease of retinal degenerations with loss of photoreceptors (related to old age or genetic) on patients' daily lives, is poorly characterize without standardized means of measurement (usually performed with functional vision or reading tasks). self-assessment by a quality of life questionnaire correlated with an assessment of …

retinitis
gene therapy
direct observation
cognitive disorders
visual loss
  • 0 views
  • 19 Feb, 2024
  • 1 location
Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression

This is a randomized, double-blind, placebo-controlled, multicenter, Phase 3 study to evaluate if high-dose Octagam 10% therapy can stabilize or improve clinical status in patients with severe Coronavirus disease

chest imaging
pao2
FIO2
throat
coronavirus infection
  • 0 views
  • 19 Feb, 2024
  • 5 locations
Healthy Test study

This is a multi center two-stage, two-arm, open label phase II study of venetoclax in combination with azacytidine in acute myeloid leukemia patients selected for therapy with ex vivo venetoclax

  • 0 views
  • 19 Feb, 2024
  • 1 location
Prophylactic Peptide Vaccine in Advanced ALK+ NSCLC

The purpose of this study is to evaluate the safety of a cancer peptide vaccine to prevent or delay acquired resistance in advanced ALK+ lung cancer patients currently on ALK targeted therapy.

  • 0 views
  • 29 Jan, 2025
  • 1 location
Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)

The investigators hypothesize that apomorphine pump is superior in terms of positive impact on quality of life (QoL) to oral medical therapy alone at a relatively early stage of PD, before the appearance of severe disabling motor complications thus favoring the maintain of patients' social and occupational status with a …

medical therapy
parkinsonism
parkinson's disease
dyskinesia
apomorphine
  • 0 views
  • 19 Feb, 2024
  • 21 locations
The Morning Coffee Study

The liking of a breakfast meal has been shown to influence food choice throughout the day. This study will investigate the effects that liking of different coffee beverages has on daily food intake.

  • 0 views
  • 19 Feb, 2024
  • 1 location
1 march 4  

The minimum acceptable dose for infusion is 1 x 10xE7 CART19 cells. Subjects originally treated under Stage 1 will receive a single infusion, if sufficient CART19 product remains. For patients from Stage 1 who do not have a sufficient dose remaining, subjects will be remanufactured under Stage 2 conditions and …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Draft-Version-001-Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases

Draft-Version-001- This study is a single center, open label exploratory clinical trial aimed at evaluating the safety and efficacy of universal CD19 CAR-T therapy in subjects with autoimmune diseases.

  • 0 views
  • 30 May, 2025